import { NextRequest, NextResponse } from "next/server"

// Mock regenerated data with some variations
const mockRegeneratedData = {
  problem:
    "Reduce viscosity of bispecific antibody solution at 180 mg/ml - Enhanced Approach",
  objectives: [
    "Evaluate advanced formulation additives for viscosity reduction",
    "Maintain protein stability and activity with enhanced monitoring",
    "Optimize processing conditions using advanced analytics",
    "Ensure manufacturability and patient compliance with new metrics",
    "Implement novel quality control measures"
  ],
  variables: [
    "Advanced Formulation Additive Type",
    "Optimized Additive Concentration",
    "Controlled Temperature Range",
    "Precise pH levels",
    "Enhanced ionic strength control"
  ],
  specialConsiderations: [
    "High protein concentration requirements with safety margins",
    "Stability maintenance critical with extended testing",
    "Subcutaneous injection compatibility with new standards",
    "Regulatory compliance requirements with additional documentation",
    "Cost-effectiveness of additives with lifecycle analysis"
  ],
  literatureFindings: {
    papers: [
      {
        title:
          "Advanced Viscosity Reduction Strategies in High-Concentration Antibody Formulations - Updated Review",
        summary:
          "Comprehensive updated review incorporating latest research on excipients and formulation approaches for reducing viscosity.",
        relevance:
          "Directly applicable to bispecific antibody formulation challenges with new insights",
        methodology:
          "Systematic review of 75+ formulation studies with advanced rheological analysis",
        pitfalls: [
          "Some excipients may compromise protein stability under stress conditions",
          "Concentration-dependent effects require careful dose-response analysis",
          "Aggregation risks with certain additives need enhanced monitoring"
        ]
      }
    ],
    searchResults: {
      totalResults: 52,
      sources: {
        pubmed: [
          {
            title:
              "Next-Generation Excipients for High-Concentration Antibody Formulations",
            authors: [
              "Smith, J.A.",
              "Johnson, B.R.",
              "Williams, C.D.",
              "New, A.B."
            ],
            abstract:
              "This updated study investigates the use of next-generation excipients including advanced trehalose derivatives, modified arginine, and novel polysorbate variants for enhanced viscosity reduction...",
            publishedDate: "2024",
            journal: "Advanced Journal of Pharmaceutical Sciences",
            citationCount: 52,
            url: "https://pubmed.ncbi.nlm.nih.gov/87654321",
            source: "pubmed" as const,
            relevanceScore: 0.97
          }
        ],
        arxiv: [],
        scholar: [],
        semanticScholar: [],
        tavily: []
      },
      synthesizedFindings: {
        keyMethodologies: [
          "Enhanced use of kosmotropic salts for improved protein stabilization",
          "Advanced combination excipient approaches for synergistic effects",
          "Precision temperature-controlled processing to minimize aggregation",
          "AI-guided pH optimization based on protein isoelectric point",
          "Next-generation rheological characterization using microfluidics"
        ],
        commonPitfalls: [
          "Overlooking protein-excipient interaction effects under stress",
          "Insufficient stability testing under accelerated conditions",
          "Inadequate viscosity measurements across extended shear rates",
          "Ignoring advanced container-closure compatibility studies",
          "Underestimating manufacturing scale-up challenges with new equipment"
        ],
        recommendedApproaches: [
          "Systematic screening of next-generation excipient combinations",
          "Use of advanced design of experiments methodology",
          "Multi-parameter optimization including enhanced stability",
          "Early-stage advanced manufacturability assessment",
          "Comprehensive analytical characterization with new techniques"
        ],
        novelInsights: [
          "AI-driven formulation prediction models showing enhanced accuracy",
          "New surfactant classes with superior protein compatibility",
          "Advanced rheological modifiers for next-gen injectable formulations",
          "Microfluidic approaches for high-throughput formulation screening",
          "Real-time viscosity monitoring during manufacturing with IoT integration"
        ]
      }
    }
  },
  dataAnalysis: {
    correlations: [
      "Enhanced negative correlation between advanced surfactant concentration and viscosity",
      "Stronger positive correlation between temperature and protein flexibility",
      "Improved correlation model between ionic strength and protein-protein interactions",
      "Refined inverse relationship between pH and aggregation tendency"
    ],
    outliers: [
      "Resolved high viscosity anomaly at moderate surfactant concentrations",
      "Identified root cause of stability loss at optimal pH conditions",
      "Characterized anomalous rheological behavior patterns",
      "Explained irregular aggregation patterns with advanced analytics"
    ],
    keyFindings: [
      "Enhanced optimal surfactant concentration range: 0.04-0.12%",
      "Refined temperature control critical below 23°C for enhanced stability",
      "Optimized pH range 6.2-6.8 provides superior viscosity-stability balance",
      "Advanced combination of modified trehalose and arginine shows enhanced synergistic effects"
    ],
    metrics: [
      "Viscosity reduction: 45-70% achievable with new approach",
      "Stability maintenance: >98% over 9 months with enhanced monitoring",
      "Aggregation levels: <1% monomer loss with advanced formulation",
      "Injection force reduction: 50-65% with optimized formulation"
    ]
  },
  experimentDesign: {
    hypothesis:
      "Incorporating next-generation formulation additives such as advanced surfactants and implementing precision processing conditions will result in enhanced reduction of the viscosity of the bispecific antibody solution at 180 mg/ml while significantly improving stability and activity profiles.",
    factors: [
      {
        name: "Advanced Formulation Additive Type",
        levels: [
          "None (Control)",
          "Advanced Surfactant A (Modified Polysorbate 80)",
          "Next-Gen Surfactant B (Enhanced Poloxamer 188)",
          "Novel Salt C (Optimized Sodium Citrate)",
          "Hybrid Additive D (Trehalose-Arginine Complex)"
        ]
      },
      {
        name: "Optimized Additive Concentration",
        levels: [
          "Low (0.04%)",
          "Medium-Low (0.08%)",
          "Medium (0.12%)",
          "Medium-High (0.16%)",
          "High (0.20%)"
        ]
      },
      {
        name: "Precision Temperature Control",
        levels: [
          "4°C ± 0.5°C (Storage)",
          "23°C ± 0.5°C (Controlled Room Temperature)",
          "37°C ± 0.5°C (Body Temperature)"
        ]
      },
      {
        name: "Enhanced pH Control",
        levels: ["6.2 ± 0.05", "6.5 ± 0.05", "6.8 ± 0.05"]
      }
    ],
    randomization:
      "Implement advanced block randomization with stratification to minimize systematic errors. Use computer-generated randomization sequences to ensure balanced representation across all factor combinations with enhanced statistical power.",
    statisticalPlan: {
      methods: [
        "Advanced factorial ANOVA with mixed-effects modeling",
        "Multiple regression analysis with machine learning validation",
        "Response surface methodology with AI optimization",
        "Post-hoc Tukey HSD tests with Bonferroni correction",
        "Bayesian analysis for uncertainty quantification"
      ],
      significance:
        "Use a significance level of 0.05 with enhanced power analysis. Advanced power analysis indicates n=4 replicates needed for 90% power to detect 15% viscosity reduction with 95% confidence."
    }
  },
  finalReport: {
    introduction:
      "Based on user feedback, this enhanced study addresses viscosity challenges in bispecific antibody formulations with advanced methodologies. The updated approach incorporates next-generation excipients and precision control systems to achieve superior viscosity reduction at 180 mg/ml while maintaining enhanced stability and activity profiles.",
    literatureSummary:
      "Updated literature review reveals breakthrough advances in excipient science and formulation design. Recent studies demonstrate enhanced opportunities for viscosity management through precision engineering and advanced analytical techniques.",
    dataInsights:
      "Enhanced analysis of expanded dataset (52 studies) reveals optimized patterns in excipient effectiveness. Advanced analytics provide refined understanding of concentration-response relationships and interaction effects.",
    hypothesis:
      "Incorporating next-generation formulation additives such as advanced surfactants and implementing precision processing conditions will result in enhanced reduction of the viscosity of the bispecific antibody solution at 180 mg/ml while significantly improving stability and activity profiles.",
    designOfExperiments:
      "The enhanced DOE incorporates user feedback with advanced factorial design evaluating 4 factors at multiple levels. Precision-controlled testing with computer-generated randomization ensures robust statistical evaluation with enhanced power and reduced bias.",
    statisticalAnalysis:
      "Advanced statistical analysis employs mixed-effects ANOVA with machine learning validation. Enhanced power analysis with Bayesian methods provides superior confidence in results and optimal factor identification.",
    recommendations:
      "Implement the enhanced precision factorial design based on user feedback. Priority on next-generation surfactant optimization with advanced concentration mapping. Enhanced analytical methods with real-time monitoring for comprehensive formulation development and scale-up success."
  }
}

export async function POST(req: NextRequest) {
  console.log("🎭 [MOCK_REGENERATE_API] Mock regenerate API called")

  try {
    const { designId, feedback, currentDesign } = await req.json()
    console.log("📥 [MOCK_REGENERATE_API] Request data:")
    console.log("  Design ID:", designId)
    console.log("  Feedback:", feedback)
    console.log("  Current Design Problem:", currentDesign?.problem)

    // Add 2 second delay to simulate real API processing
    console.log(
      "⏳ [MOCK_REGENERATE_API] Simulating 2-second regeneration delay..."
    )
    await new Promise(resolve => setTimeout(resolve, 2000))

    console.log(
      "✅ [MOCK_REGENERATE_API] Returning mock regenerated design data"
    )
    return NextResponse.json({
      success: true,
      design: mockRegeneratedData,
      searchMetrics: {
        totalPapers: 52,
        searchStrategy: "enhanced multi-source with user feedback integration",
        queryOptimization: 3,
        sourceBreakdown: {
          pubmed: 1,
          arxiv: 0,
          semanticScholar: 0,
          scholar: 0,
          tavily: 0
        },
        feedbackIntegration: "enhanced with advanced keyword analysis"
      }
    })
  } catch (error) {
    console.error("❌ [MOCK_REGENERATE_API] Error:", error)
    return NextResponse.json(
      { success: false, error: "Mock regenerate API error" },
      { status: 500 }
    )
  }
}
